Related Experiment Video

Updated: Oct 10, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

A study on recruitment of black Americans into clinical trials through a cultural competence lens

F H Outlaw1, J N Bourjolly, F K Barg

  • 1Psychiatric Mental Health Program, University of Pennsylvania School of Nursing, Philadelphia 19104, USA.

Cancer Nursing
|December 29, 2000
PubMed

Insights

Black Americans face higher cancer rates but are underrepresented in clinical trials. Addressing physician-identified barriers through cultural competence is key to improving participation and cancer care equity.

Area of Science:

  • Oncology
  • Health Disparities
  • Clinical Trial Recruitment

Background:

  • Black Americans experience a disproportionately high burden of cancer.
  • Underrepresentation of Black Americans in clinical trials limits treatment advancements and prevention strategies.
  • Clinical trial participation offers access to cutting-edge therapies and research-driven care.

Purpose of the Study:

  • To report findings from the initial phase of a project focused on recruiting Black Americans into clinical trials.
  • To identify physician and data manager perspectives on barriers to Black American participation in clinical trials.
  • To analyze these barriers through a cultural competence framework.

Main Methods:

  • Phase one involved surveying physicians and data managers at a major urban cancer center.
  • Participants were asked to identify factors hindering Black American enrollment in clinical trials.
  • Findings were interpreted using a cultural competence lens.

Main Results:

  • Identified factors align with existing literature on perceived barriers to clinical trial participation for Black Americans.
  • The cultural competence perspective offers a novel approach to understanding these barriers.
  • This phase sets the stage for assessing patient knowledge, beliefs, and behaviors in phase two.

Conclusions:

  • Physician and staff perceptions of barriers are consistent with current research.
  • A cultural competence framework provides new insights for developing targeted interventions.
  • Addressing these barriers is crucial for achieving equitable representation in cancer clinical trials.

More Related Videos

Collecting Hair Samples for Hair Cortisol Analysis in African Americans06:01

Collecting Hair Samples for Hair Cortisol Analysis in African Americans

Published on: June 10, 2018

The Sol Braiding Method for Handling Thick Hair During Transcranial Magnetic Stimulation: An Address for Potential Bias in Brain Stimulation04:37

The Sol Braiding Method for Handling Thick Hair During Transcranial Magnetic Stimulation: An Address for Potential Bias in Brain Stimulation

Published on: August 9, 2024

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Surveys02:16

Surveys

Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...